Control of chondrocyte gene expression by actin dynamics: A novel role of cholesterol/Ror-α signalling in endochondral bone growth

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 9 B, 2009, Pages 3497-3516

  Woods, Anita ^a   James, Claudine G ^a   Wang, Guoyan ^a   Dupuis, Holly ^a   Beier, Frank ^a  

^a WESTERN UNIVERSITY   (Canada)

Author keywords

Actin cytoskeleton; Cholesterol; Chondrocytes; Hypertrophy; Microarray; Nuclear receptors; Rho GTPases; Ror

Indexed keywords

ACTIN; CHOLESTEROL; CYTOCHALASIN D; RETINOID RELATED ORPHAN RECEPTOR ALPHA;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; BONE; BONE DEVELOPMENT; CARTILAGE CELL; CELL CULTURE; CYTOLOGY; GENE EXPRESSION REGULATION; METABOLISM; MOUSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TIME;

ACTINS; ANIMALS; BONE AND BONES; BONE DEVELOPMENT; CELLS, CULTURED; CHOLESTEROL; CHONDROCYTES; CYTOCHALASIN D; GENE EXPRESSION REGULATION; MICE; MODELS, BIOLOGICAL; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TIME FACTORS;

MUS;

EID: 73549119107     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00684.x     Document Type: Article

References (65)

1. Hunziker EB. Mechanism of longitudinal bone growth and its regulation by growth plate chondrocytes. Microsc Res Tech. 1994, 28:505-19.
2. Noonan KJ, Hunziker EB, Nessler J. Changes in cell, matrix compartment, and fibrillar collagen volumes between growth-plate zones. J Orthop Res. 1998, 16:500-8.
3. Abad V, Meyers JL, Weise M. The role of the resting zone in growth plate chondrogenesis. Endocrinology. 2002, 143:1851-7.
4. Hunziker EB, Schenk RK, Cruz-Orive LM. Quantitation of chondrocyte performance in growth-plate cartilage during longitudinal bone growth. J Bone Joint Surg Am. 1987, 69:162-73.
5. Wilsman NJ, Farnum CE, Leiferman EM. Differential growth by growth plates as a function of multiple parameters of chondrocytic kinetics. J Orthop Res. 1996, 14:927-36.
6. Beier F. Cell-cycle control and the cartilage growth plate. J Cell Physiol. 2005, 202:1-8.
7. Breur GJ, VanEnkevort BA, Farnum CE. Linear relationship between the volume of hypertrophic chondrocytes and the rate of longitudinal bone growth in growth plates. J Orthop Res. 1991, 9:348-59.
8. Karsenty G, Wagner EF. Reaching a genetic and molecular understanding of skeletal development. Dev Cell. 2002, 2:389-406.
9. Schwartz NB, Domowicz M. Chondrodysplasias due to proteoglycan defects. Glycobiology. 2002, 12:57-68.
10. Spranger J, Winterpacht A, Zabel B. The type II collagenopathies: a spectrum of chondrodysplasias. Eur J Pediatr. 1994, 153:56-65.
11. Drissi H, Zuscik M, Rosier R. Transcriptional regulation of chondrocyte maturation: potential involvement of transcription factors in OA pathogenesis. Mol Aspects Med. 2005, 26:169-79.
12. Aigner T, Gerwin N. Growth plate cartilage as developmental model in osteoarthritis reserach-potentials and limitations. Curr Drug Targets. 2007, 8:377-85.
13. James CG, Appleton CT, Ulici V. Microarray analyses of gene expression during chondrocyte differentiation identifies novel regulators of hypertrophy. Mol Biol Cell. 2005, 16:5316-33.
14. Woods A, Wang G, Beier F. RhoA/ROCK signaling regulates Sox9 expression and actin organization during chondrogenesis. J Biol Chem. 2005, 280:11626-34.
15. Woods A, Beier F. RhoA/ROCK signaling regulates chondrogenesis in a context-dependent manner. J Biol Chem. 2006, 281:13134-40.
16. Wang G, Woods A, Sabari S. RhoA/ROCK signaling suppresses hypertrophic chondrocyte differentiation. J Biol Chem. 2004, 279:13205-14.
17. Benya PD, Brown PD, Padilla SR. Microfilament modification by dihydrocytochalasin B causes retinoid acid-modulated chondrocytes to re-express the differentiated collagen phenotype without a change in shape. J Cell Biol. 1988, 106:161-70.
18. Brown PD, Benya PD. Alterations in chondrocyte cytoskeletal architecture during phenotypic modulation by retinoic acid and dihydrocytochalasin B-induced reexpression. J Cell Biol. 1988, 106:171-9.
19. Benya PD. Modulation and re-expression of the chondrocyte phenotype; mediation by cell shape and microfilament modification. Pathol Immunopathol Res. 1988, 7:51-4.
20. Newman SA, Watt FM. Influence of cytochalasin D induced changes in cell shape on proteoglycan sythesis by cultured articular chondrocytes. Exp Cell Res. 1988, 178:199-210.
21. Loty S, Forest N, Boulekbache H. Cytochalasin D induces changes in cell shape and promotes in vitro chondrogenesis: a morphological study. Biol Cell. 1995, 83:149-61.
22. Agoston H, Khan S, James CG. C-type natriuretic peptide regulates endochondral bone growth through p38 MAP kinase-dependent and independent pathways. BMC Devl Biol 2007, 7:18.
23. Ulici V, Hoenselaar KD, Gillespie JR. The PI3K pathway regulates endochondral bone growth through control of hypertrophic chondrocyte differentiation. BMC Dev Biol 2008, 11:40.
24. Wang G, Woods A, Agoston H. Genetic ablation of Rac1 in cartilage results in chondrodysplasia. Dev Biol. 2007, 306:612-23.
25. James CG, Ulici V, Tuckermann J. Expression profiling of dexamethasone treated primary chondrocyte identifies targets of glucocorticoid signaling in endochondral ossification development. BMC Genomics 2007, 8:205.
26. Kang HS, Angers M, Beak JY. Gene expression profiling reveals a regulatory role for ROR alpha and ROR gamma in phase I and phase II metabolism. Physiol Genomics. 2007, 31:281-94.
27. James CG, Woods A, Underhill TM. The transcription factor ATF3 is upregulated during chondrocyte differentiation and represses cyclin D1 and A gene transcription. BMC Mol Biol 2006, 7:30.
28. Bursell L, Woods A, James CG. Src kinase inhibition promotes the chondrocyte phenotype. Arthritis Res Ther 2007, 9:R105.
29. Bubb M, Senderowicz A, Sausville E. Jasplakinolide, a cytotoxic natural product, induces actin polyerization and competitively inhibits the binding of phalloidin to F-actin. J Biol Chem. 1994, 269:14869-71.
30. Goddette DW, Frieden C. The kinetics of cytochalasin D binding to monomeric actin. J Biol Chem. 1986, 261:15970-3.
31. Miralles F, Posern G, Zaromytidou A-I. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell. 2003, 113:329-42.
32. Al-Shahrour F, Carbonell J, Minquez P. Babelomics: advanced functional profiling of transcriptomics, proteomics and genomics experiments. Nucleic Acids Res. 2008, 36:W341-6.
33. Shao YY, Wang L, Hicks DG. Expression and activation of peroxisome proliferator-activated receptors in growth plate chondrocytes. J Orthop Res. 2005, 23:1139-45.
34. Hill TP, Spater D, Taketo MM. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell. 2005, 8:727-38.
35. Li TF, O'Keefe RJ, Chen D. TGF-beta signaling in chondrocytes. Front Biosci. 2005, 1:681-8.
36. Stanton LA, Beier F. PPARgamma2 expression in growth plate chondrocytes is regulated by p38 and GSK-3. J Cell Mol Med 10.1111/j.1582-4934.2008.00396.x, DOI
37. Enomoto-Iwamoto M, Kitagawa J, Koyama E. The Wnt antagonist Frzb-1 regulates chondrocyte maturation and long bone development during limb skeletogenesis. Dev Biol. 2002, 251:142-56.
38. Coleman CM, Tuan RS. Functional role of growth/differentiation factor 5 in chondrogenesis of limb mesenchymal cells. Mech Dev. 2003, 120:823-36.
39. Cunningham NS, Jenkins NA, Gilbert DJ. Growth/differentiation factor-10: a new member of the transforming growth factor-beta superfamily related to bone morphogenetic protein-3. Growth Factors. 1995, 12:99-109.
40. Schipani E, Ryan HE, Didrickson S. Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev. 2001, 15:2865-76.
41. Chauvet C, Bois-Joyeux B, Berra E. The gene encoding human retinoic acid-receptor-related orphan receptor alpha is a target for hypoxia-inducible factor 1. Biochem J. 2004, 384:79-85.
42. Kallen JA, Schlaeppi JM, Bitsch F. X-ray structure of the hRORalpha LBD at 1.63 A: structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORalpha. Structure. 2002, 10:1697-707.
43. Wiesenberg I, Missbach M, Kahlen JP. Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. Nucleic Acids Res. 1995, 23:327-33.
44. Alberts AW, Chen J, Kuron G. Mevinolin: A highly potent competitve inhibitor of hydroxymethylglutaryl coenzyme A reductase and a cholesterol-lowering agent. Proc Natl Acad Sci USA. 1980, 77:3957-61.
45. Lau P, Nixon SJ, Parton RG. RORalpha regulates the expression of genes involved in lipid homeostasis in skeletal muscle cells: caveolin-3 and CPT-1 are direct targets of ROR. J Biol Chem. 2004, 279:36828-40.
46. Pfander D, Cramer T, Deuerling D. Expression of thrombospondin-1 and its receptor CD36 in human osteoarthritic cartilage. Ann Rheum Dis. 2000, 59:448-54.
47. Mic FA, Molotkiv A, Fan X. RALDH3, a retinaldehyde dehydrogenase that generates retinoic acid, is expressed in the ventral retina, otic vesical and olfactory pit during mouse development. Mech Dev. 2000, 97:227-30.
48. Gray S, Wang B, Orihuela Y. Regulation of gluconeogenesis by Kruppel-like factor 15. Cell Metab. 2007, 5:305-12.
49. Schnabel M, Marlovits S, Eckhoff G. Dedifferentiation-associated changes in morphology and gene expression in primary human articular chondrocytes in cell culture. Osteoarthritis Cartilage. 2002, 10:62-70.
50. Mallein-Gerin F, Garrone R, van der Rest M. Proteoglycan and collagen synthesis are correlated with actin organization in dedifferentiating chondrocytes. Eur J Cell Biol. 1991, 56:364-73.
51. Woods A, Wang G, Beier F. Regulation of chondrocyte differentiation by the actin cytoskeleton and adhesive interactions. J Cell Physiol. 2007, 213:1-8.
52. Uribe R, Jay D. A review of actin binding proteins: new perspectives. Mol Biol Rep. 2009, 36:121-5.
53. Loy CJ, Sim KS, Yong EL. Filamin-A fragment localizes to the nucleus to regulate androgen receptor and coactivator functions. Proc Natl Acad Sci USA. 2003, 100:4562-7.
54. Gerber HP, Vu TH, Ryan AM. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med. 1999, 5:623-8.
55. Shen Z, Gantcheva S, Mansson B. Chondradherin expression changes in skeletal development. Biochem J. 1998, 330:549-57.
56. Dreier R, Opolka A, Grifka J. Collagen IX-deficiency seriously compromises growth cartilage development in mice. Matrix Biol. 2008, 27:319-29.
57. Hasky-Negev M, Simsa S, Tong A. Expression of matrix metalloproteinases during vascularization and ossification of normal and impaired avian growth plate. J Anim Sci. 2008, 86:1306-15.
58. Steinmayr M, Andre E, Conquet F. Staggerer phenotype in retinoid-related orphan receptor alpha-deficient mice. Proc Natl Acad Sci USA. 1998, 95:3960-5.
59. Raspe E, Duez H, Gervois P. Transcriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor RORalpha. J Biol Chem. 2001, 276:2865-71.
60. Meyer T, Kneissel M, Mariani J. In vitro and in vivo evidence for orphan nuclear receptor RORalpha function in bone metabolism. Proc Natl Acad Sci USA. 2000, 97:9197-202.
61. Kopmels B, Mariani J, Delhaye-Bouchaud N. Evidence for a hyperexcitability state of staggerer mutant mice macrophages. J Neurochem. 1992, 58:192-9.
62. Wang G, Beier F. Rac1/Cdc42 and RhoA GTPases antagonistically regulate chondrocyte proliferation, hypertrophy, and apoptosis. J Bone Miner Res. 2005, 20:1022-31.
63. Seabra MC. Membrane association and targeting of prenylated Ras-like GTPases. Cell Signal. 1998, 10:167-72.
64. Sidman RL, Lane PW, Dickie MM. Staggerer, a new mutation in the mouse affecting the cerebellum. Science. 1962, 137:610-2.
65. Wu S, De Luca F. Role of cholesterol in the regulation of growth plate chondrogenesis and longitudinal bone growth. J Biol Chem. 2004, 279:4642-7.